Completed Research: Innovation and Technology Policy

  • Grand Challenges in International Research Cooperation

    21 Oct 2014

    Horizon 2020, the EU’s biggest research funding programme, allows the EU to play a central role in solving some of the world’s grand societal challenges. To best meet these challenges, the EU should agree on strategic research agendas with partner countries including the US, India, and China, and to establish further links with other intergovernmental initiatives.

  • Developing EU Information Security and Data Protection Frameworks

    22 Sep 2014

    Has Brussels put its own house in order when it comes to information security and data privacy? RAND Europe research suggests that the EU institutions and agencies should review the rules that govern their information security and data privacy procedures if they want to be ahead of the ICT innovation curve.

  • Exploring the Current State of Health Research in Sub-Saharan Africa

    19 Sep 2014

    While funding is the key problem, clinical researchers seeking to combat infectious diseases in sub-Saharan Africa cite the lack of policymaker understanding of the importance of their work as a major barrier, above lack of human resources and lack of infrastructure.

  • Evaluating the Wellcome Trust's African Institutions Initiative

    12 Sep 2014

    An evaluation of the Wellcome Trust's African Institutions Initiative (AII) shows several successes as well as recommendations for the future. The AII funds consortia to build sustainable, independent health research capacity at African universities and research organisations, to promote research collaboration and to train individuals for research careers in Africa.

  • Are You Sitting Comfortably?

    02 Sep 2014

    A range of emerging, but important, risks to our Internet-connected living room have implications for security and privacy, according to research by RAND Europe for Ofcom. Addressing these might require more action from government, industry and consumers alike.

  • Estimating the Economic Returns on Cancer Research in the UK

    16 Jun 2014

    The UK government invests approximately £1.6 billion in medical research each year, and the British public donated £1.7 billion to medical research charities in 2012-13. Research shows that this funding delivers health gains for patients and also benefits the UK economy at a 40% return annually.

  • Assessing the Real-World Data Policy Landscape for Health and Healthcare in Europe

    24 Apr 2014

    RAND Europe, supported by IBM, worked through a multi-method approach to assess different pathways for collecting and utilising real world data (RWD) in the health and healthcare sector. Based on a literature review, case studies, a small set of interviews of experts from public and private organisations, and a scenario-based workshop, researchers have outlined possible strategies to illustrate how the development of standards could facilitate RWD-based research.

  • Local Context is Key in Successfully Using ARVs to Prevent HIV/AIDS

    31 Mar 2014

    The Mapping Pathways project, in which RAND Europe is a partner, explores the complex issues surrounding the use of antiretroviral (ARV) therapy as HIV prevention. The second phase of the project produced a report that brings together scientific evidence and community perspectives on four strategies for ARV-based HIV prevention and emphasises how local context shapes perception of evidence. Three subsequent workshops examine the local context in greater detail.

  • Mapping Smart Cities in the EU

    25 Mar 2014

    The European Parliament asked RAND Europe to provide background information and advice to their members on the role of Smart Cities initiatives and to explain how existing mechanisms perform. The researchers established a working definition of a Smart City and mapped the cities fitting this definition across the Member States. An analysis of the Smart Cities initiatives found that Smart Cities objectives should be more explicit, well defined and clearly aligned to city development, innovation plans and Europe 2020 to be successful.

  • Evaluation of the Structural Genomics Consortium

    10 Mar 2014

    The Structural Genomics Consortium (SGC) is a not-for-profit, public-private partnership formed to support drug-discovery through pre-competitive structural biology research. The SGC has commissioned RAND Europe and Canada's Institute on Governance to provide an evaluation of its unique, open-access model, to understand the nature and diversity of its benefits for partnering organisations as well as for the wider research community.

  • How to Increase Value and Reduce Waste When Research Priorities Are Set

    08 Jan 2014

    Jonathan Grant has co-authored a paper on how to increase value and reduce waste when research priorities are set, launched today in The Lancet. The message is that policymakers, research funders and researchers must make more use of prior research results, systematic reviews and patients’ own views, when deciding what research to perform. It is also important to consider how to get the maximum impact from each research project, which RAND Europe researchers have explored in their Retrosight projects.

  • Examining Europe's Policy Options to Foster Development of the 'Internet of Things'

    06 Nov 2013

    The Internet of Things (IoT) has the potential to fundamentally change the future, as billions of objects around us will be connected to make our lives easier. The European Commission hopes to devise a policy stance capable of fostering a dynamic and trustworthy IoT. RAND Europe research is informing this policy, based on the current state of play and probable developments, from a technological, economic and policy point of view.

  • Mental Health Retrosight Study Sheds Light on What Makes Biomedical Research More Likely to Benefit Patients

    28 Oct 2013

    The Mental Health Retrosight study of 20 years of research in the field of schizophrenia shows how research projects that successfully translated into patient benefit share certain characteristics, such as multidisciplinary researchers or teams, and clinically-oriented rather than basic research topics. These attributes could be selected for, promoted or nurtured to increase the impact of future research on improving patients’ lives.

  • The Global Threat of Antimicrobial Resistance

    18 Sep 2013

    To head off the growing threat of drugs no longer working in the war against microbes, Dame Sally C Davies, Chief Medical Officer for England, together with Dr Jonathan Grant and Professor Mike Catchpole, have written The Drugs Don't Work. The book brings together in one easy read the startling facts of the here-and-now problem we face about resistance to our current range of antimicrobial drugs, with expert analysis of the science behind and policy implications of the battle against infectious diseases.

  • Peer Review Not the Only Option for Selecting Research Projects to Fund

    18 Apr 2013

    As a method for awarding research funding, peer review suffers from many drawbacks and yet is by far the most commonly used method to make funding decisions. RAND Europe revised and updated its pack of Alternatives to Peer Review to inspire funders to practise and test alternative methods for picking research winners.

  • Examining the Future Outlook for Breast Cancer in the UK

    05 Apr 2013

    Breakthrough Breast Cancer, a UK-based research charity, commissioned RAND Europe to conduct a study to determine the future outlook for breast cancer. This work informed the development of Breakthrough’s future strategic direction, helping them to achieve the best possible outcomes for people affected by breast cancer.

  • Assessing Research Impact: An International Review of the Excellence in Innovation for Australia Trial

    27 Mar 2013

    The Excellence in Innovation for Australia (EIA) Impact Assessment Trial aimed to assess the non-academic impact of research generated by a subset of Australian universities, and act as a pilot for a potential companion piece to the next Excellence in Research for Australia (ERA), a nationwide performance assessment of Australian universities. RAND Europe's evaluation of the Trial found it to be a successful process, but identified a number of areas of improvement, especially if it is scaled up to a national level.

  • Examining How Regulatory Cultures Affect Research Governance

    05 Mar 2013

    Health research governance in the UK has been the subject of much debate and discussion in recent years as existing regulatory approaches and processes have been consolidated and reconsidered. Researchers looked at the behavior of regulated sectors in different areas and countries—including medical drugs, financial services, and environmental sectors—to seek relevant lessons to help understand the impact of regulation on health research governance.

  • Impact of the Data Protection Review on EU Innovation and Competitiveness

    21 Dec 2012

    RAND Europe provided the European Parliament's Committee on Industry, Research and Energy with a rapid assessment of the innovation and competitiveness impacts of the EU's proposed General Data Protection Regulation affecting: automated processing; control of data processing; and data transfers. The briefing considers a variety of perspectives—profiling; big data; cloud computing; and privacy-friendly technologies—and identifies a variety of impacts and areas for improvement.

  • Study Supports UK Government Estimates that Scientific Research Will Promote Economic Growth

    05 Dec 2012

    The UK government today announced plans to spend £600 million for scientific research, in part as a means for promoting economic growth. Evidence provided by research findings in a 2008 study by RAND Europe, the Health Economics Research Group at Brunel University, and the Office of Health Economics suggests that the proposal could lead to a good return on investment. The study estimated that the health and GDP gains from UK public and charitable investments in cardiovascular disease research is equivalent to an annual rate of return of around 39%.

  • Understanding the Interactions Between Public–Private Partnerships and Personalised Medicine

    28 Sep 2012

    The field of personalised or stratified medicine is evolving alongside the formation of a plethora of public-private partnerships. Such collaborations are at the core of the set of new life sciences policies in the UK, but the rationale and basis for collaboration remains unclear and there is little indication in policy documents of clear boundaries for them. An article in the journal New Biotechnology discusses some of the drivers and dynamics of these collaborations.

  • Future Internet Public-Private Partnership Can Help Europe Be More Competitive

    20 Aug 2012

    The Internet has transformed our daily lives and revolutionised the way we do business, and it promises to fuel economies and improve well-being in the future. But Europe has been slower than the US, Korea or Japan to capture the full benefits of the Internet economy. Investing in new technologies and applications has considerable economic potential for Europe, but only if some tough choices are made and barriers to EU international competitiveness can be overcome.

  • As 'Smart Trash,' RFID Tags Have Both Environmental Advantages and Impacts

    03 Jul 2012

    Radio Frequency Identification (RFID) tags offer benefits to product lifecycle management and can help indicate how best to recycle products, but they also introduce extraneous metals and materials into the recycling stream. RAND Europe and its two research partners explored the environmental impact and advantages of using RFID tags and provide recommendations based on their findings.

  • Exploring Incentives and Barriers to the Cyber Insurance Market in Europe

    02 Jul 2012

    Although concerns about cyber-security are one of the top five global risks identified by the World Economic Forum, it is less clear whether the market for cyber-insurance is sufficiently mature. ENISA asked RAND Europe to explore what might inhibit such a market and investigate incentives to kick-start its development. Recommendations include collecting more empirical evidence, exploring the scope for collective action or redress, develop frameworks to help firms appraise the value of their information, and explore the role of government as an insurer of last resort.

  • Examining Innovation in Crowdsourcing-Based Business Models

    25 Jun 2012

    Open innovation has gained increased attention as a potential paradigm for improving innovation performance, but one under-researched type of innovation is crowdsourcing, where a crowd is tasked with solving problems which solution seekers anticipate to be empirically provable. An exploration of who is using this form of innovation and how, looking at the potential diversity and core features and variables implicated in crowdsourcing models, can help organisations understand the effectiveness, best practices, challenges and implications of crowdsourcing.